{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-122266","form_type":"8-K","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.032558+00:00","generated_at":"2026-05-30T04:36:01.840920+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"RevMed Q3 net loss $156M; Phase 3 PDAC trial started, RMC-9805 initial data","bullets":["Net loss of $156.3M for Q3 2024 vs. $108.4M in Q3 2023; R&D expenses rose to $151.8M.","Cash, equivalents and securities were $1.55B as of Sept 30, 2024; funding projected into 2027.","Phase 3 RASolute 302 trial of RMC-6236 in metastatic PDAC dosed first patient; data event-driven.","Initial RMC-9805 (KRAS G12D inhibitor) data show encouraging safety and antitumor activity; 1200 mg once daily candidate Phase 2 dose.","FY 2024 GAAP net loss guidance reiterated at $560M-600M; NSCLC and combination data due in Q4 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-122266","json":"https://secwatch.observer/filing/0000950170-24-122266.json","markdown":"https://secwatch.observer/filing/0000950170-24-122266.md","text":"https://secwatch.observer/filing/0000950170-24-122266.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000095017024122266/0000950170-24-122266-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000095017024122266/rvmd-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:36:01.840920+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}